-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2019 to Q3 2025.
- Autolus Therapeutics plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 266M shares, a 0.02% increase year-over-year.
- Autolus Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 255M shares, a 46.7% increase from 2023.
- Autolus Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 174M shares, a 83.1% increase from 2022.
- Autolus Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 95M shares, a 31.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)